PRESIDENT & CHIEF SCIENTIFIC OFFICER

President and Chief Scientific Officer The Beth Israel Lahey Health (BILH), Joslin Diabetes Center is seeking applications and nominations for the position of President and Chief Scientific Officer. An academic appointment as Full or Associate Professor in the Field of Diabetes at Harvard Medical School (HMS) will be commensurate with experience, training, and achievements in addition to teaching activities. Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. As one of only 18 NIH-designated Diabetes Research Center in the United States serving more than 20,000 adults and children each year, Joslin sets the standard for diabetes treatment by providing highly specialized care and education. Its clinical models are recognized as the standard care for treating diabetes and related complications in both the United States and around the world. The center’s team of diabetes educators, including nurses, dieticians and exercise physiologists, are nationally certified by the American Diabetes Association, ensuring the highest quality of care and education for patients. The President & Chief Scientific Officer will serve as a visionary leader responsible for defining and advancing the scientific and strategic direction of Joslin Diabetes Center. This individual will oversee all core departments, including Research, Clinical Services, Fiscal Services, Philanthropy, Commercial Ventures and Quality, ensuring integration with BILH while maintaining Joslin’s identity as an independent center of excellence. In close collaboration with BILH leadership, the Joslin Board of Trustee’s and Harvard Medical School, the President & Chief Scientific Officer will align research, clinical and educational missions to drive innovation, sustainability, and impact in diabetes care and discovery. Applicants should be nationally or internationally recognized leaders in academic medicine or diabetes research with a proven track record of scientific achievement, programmatic leadership, and team development. They must demonstrate a vision for advancing academic accomplishment and demonstrate the leadership skills to nurture and enhance the research, teaching, and clinical portfolios of an outstanding Field of Diabetes. They will also serve as a member of the HMS-wide Diabetes Executive Committee, which collaborates academically with the other HMS teaching hospitals. Therefore, they must have exemplary administrative, operational, financial, academic mentoring, and communication acumen, not only to build and lead, but also to engage with institutional, departmental, and divisional leaders, the Harvard community, as well as the regional, national, and international diabetes communities. The ideal candidate will have the ability to inspire collaboration, drive innovation, and advance Joslin’s global reputation as a pioneer in diabetes treatment and research. Prospective applicants should apply directly to the Workday posting. For any questions, please direct them to : Committee Chair: Mark Zeidel, MD Chair, Department of Medicine and Physician in Chief, BIDMC Herrman L. Blumgart Professor of Medicine, HMS mzeidel@bidmc.harvard.edu Link to apply Link to apply The pay range listed for this position is $350,000-$540,000, which is the annual base salary range the organization reasonably and in good faith expects to pay for this position at this time. In addition to base compensation, this position may be eligible for additional compensation, which may include performance-based incentive bonuses. We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law. Compensation Information $350,000.00 / Annually - $540,000.00 / Annually #J-18808-Ljbffr